Raw Tirzepatide powder is the powdered form of the active pharmaceutical ingredient (API) used in Mounjaro or other Tirzepatide related drug. It requires professional production technology to make various Tirzepatide related finished products from raw Tirzepatide powder. The appearance of raw tirzepatide powder is white, CAS number is 2023788-19-2.
Benefits Of Tirzepatide
Promote weight loss. Tirzepatide has been shown to reduce food intake, suppress appetite and regulate fat utilization. Numerous clinical studies have shown that patients taking Tirzepatide lost 15.7% (34.4 pounds or 15.6 kilograms) of body weight, making it a potential option for those seeking effective weight management.
Increases satiety. Tirzepatideslows the passage of food through the body, reduces the desire to eat, and enhances the body's feeling of fullness, making it easier to stick to a healthy diet and maintain weight loss.
Control and stabilize blood sugar levels. Type 2 diabetes is a chronic progressive disease and the most common form of diabetes. This disease causes the body's own inability to release insulin, resulting in high levels of glucose in the blood. Tirzepatidecan regulate the release and use of insulin by regulating GLP-1 and GIP, thereby keeping glycated hemoglobin (HbA1c) at a healthy level.
Treat type 2 diabetes. Tirzepatidepeptide has been approved by the FDA for the treatment of type 2 diabetes and can effectively help patients control blood sugar. Regulates blood sugar levels mainly by increasing the secretion of insulin.
Treat obesity-related diseases. Obesity can lead to physical diseases such as high blood pressure, hyperglycemia, hyperlipidemia, and even heart disease. Tirzepatidecan effectively reduce the occurrence and development of these diseases while protecting the cardiovascular system by promoting weight loss.
Treat obese with type 1 diabetes: The latest research shows that Tirzepatide may help obese type 1 diabetes also. Researchers reported that Tirzepatide led to an average weight loss of 18.5% (>46 pounds) in patients with type 1 diabetes over one year and improved glycemic control.